icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Treatment with Glecaprevir/Pibrentasvir (G/P)-based regimens of patients with difficult to treat HCV infection. A compassionate use study.
 
 
  Reported by Jules Levin
AASLD - American Association for the Study of Liver Diseases (AASLD) Congress, October 20-24, 2017, Washington, DC, USA
 
Victor de Ledinghen, Anne Varaut, Jose Ursic-Bedoya, Jean-Baptiste Hiriart, Giovanna Scoazec, Wassil Merrouche, Georges Philippe Pageaux, Christophe Hezode Bordeaux - Creteil - Montpellier (France)

1027171

1027172

1027173